-
1 Comment
Aedifica SA is currently in a long term uptrend where the price is trading 17.5% above its 200 day moving average.
From a valuation standpoint, the stock is 152.3% more expensive than other stocks from the Real Estate sector with a price to sales ratio of 16.3.
Based on the above factors, Aedifica SA gets an overall score of 1/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | BE0003851681 |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
Beta | 0.94 |
---|---|
Market Cap | 3B |
PE Ratio | 16.52 |
Target Price | 71.9333 |
Dividend Yield | 6.1% |
Aedifica is a regulated real estate company under Belgian law specializing in European healthcare real estate and more particularly in healthcare real estate elderly people. Aedifica has developed a portfolio of more than 600 sites in Belgium, Germany, the Netherlands, the United Kingdom, Finland, Ireland and Spain, worth more than "6.1 billion. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019) and is identified by the following codes: AED; AED:BB (Bloomberg); AOO.BR (Reuters). Since 2020, Aedifica has been part of the BEL20, the main stock market index of EuronextBrussels. In addition, since 2023, Aedifica has been part of the BEL ESG, the index that tracks the most performing well on ESG criteria. Aedific is part of the ERRA, StoxxEurope600 and GPR. Its market capitalization was approximately "3.3 billion as of April 29, 2025.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for AOO.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025